Related Experiment Video
Updated: Jan 19, 2026

Personalized Needles for Microinjections in the Rodent Brain
Published on: January 24, 2018
Erasing the Personal Baseline: Graphing Responders to Psychiatric Drug Maintenance Therapy
1Dorian Deshauer - Department of Psychiatry, University of Toronto Originally submitted 29 March 2019; accepted 17 May 2019.
Abstract:
Since the 1950s, the practice of psychiatric drug maintenance therapy has been supported by graphics. Lacking physical markers to identify "responders" to long-term drugs, psychiatrists have used graphics to make the outcomes of their interventions visible. This article identifies changes in the graphical representation of drug responders in psychiatric journals between the mid-1950s and the mid-1990s. It argues that before 1970, psychiatrists assessed patients' responses in relation to their personal baselines or symptom trajectories. After 1970, clinical trials made it possible to see responders through a statistical lens, as a homogeneous population, decontextualized from its past and having a future consisting of two possible states: relapse or remission. Abstracted from their life's context, responders became the desired outcome of prescribing protocols that could be applied anywhere. Psychiatry's graphical language supported an authoritative view of mental health as something to be optimized and maintained with prescription drugs.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Therapy
Antianxiety Medications
10:06Personalized Needles for Microinjections in the Rodent Brain
Ogive Graph
Graphing Antiderivatives
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...